Ophiuroid (Echinodermata) systematics-where do we come from, where do we stand and where should we go?

被引:17
|
作者
Stohr, Sabine [1 ]
机构
[1] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden
关键词
Echinodermata; Ophiuroidea; diversity; morphology; history of science; BRITTLE STARS ECHINODERMATA; POSTLARVAL DEVELOPMENT; ATLANTIC; MITOCHONDRIAL; MORPHOLOGY; COMPLEX; GENERA;
D O I
10.11646/zoosymposia.7.1.14
中图分类号
Q17 [水生生物学];
学科分类号
071004 ;
摘要
Over 2,000 Recent species of brittle star are currently known. The most active period of species discovery was between 1850 and 1950, with an average rate of about 20 new species per year, but even today, an average of 7 species per year are described. The most prolific authors were R. Koehler, H.L. Clark, T. Lyman, T. Mortensen and C. Lutken. Early classifications divided the Ophiuroidea into Euryalida and Ophiurida. Matsumoto suggested in 1917 further subdivision, accepted by some authors, rejected by others. His classification is still the most comprehensive work available. A first modern cladistic analysis was presented in 1995 by Smith et al., but despite its shortcomings, no further attempts at reconstructing the phylogeny of the whole class have been made. It is becoming increasingly clear that Ophiuroidea have undergone rapid evolution after the great extinction event at the Permian/Triassic boundary, complicating phylogenetic analysis both with morphological and molecular data. Palaeozoologists still debate which ophiuroid group(s) survived the extinction. It has been suggested that the modern families Ophiuridae and Ophiolepididae may be traced back to the Palaeozoic, but the traditional view puts Ophiacanthidae and Ophiomyxidae at the root of the tree, with Euryalida as ancient sister group to Ophiurida. Unusual species with aberrant traits abound, but are still poorly understood. New morphological approaches, such as the study of the internal skeleton (jaws, dental plates, lateral arm plates), ontogeny and the role of paedomorphosis, as well as the extensive use of SEM for microstructure examinations, attempt to improve our understanding of the diversity and evolution of brittle stars.
引用
收藏
页码:147 / 161
页数:15
相关论文
共 50 条
  • [1] Smart energy: where do we stand and where should we go?
    Kranz, Johann
    Kolbe, Lutz M.
    Koo, Chulmo
    Boudreau, Marie-Claude
    [J]. ELECTRONIC MARKETS, 2015, 25 (01) : 7 - 16
  • [2] Smart energy: where do we stand and where should we go?
    Johann Kranz
    Lutz M. Kolbe
    Chulmo Koo
    Marie-Claude Boudreau
    [J]. Electronic Markets, 2015, 25 : 7 - 16
  • [3] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    [J]. TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [4] Where do we come from, where do we go from here?
    Ammann, K
    Ammann, BP
    [J]. METHODS FOR RISK ASSESSMENT OF TRANSGENIC PLANTS, VOL III: ECOLOGICAL RISKS AND PROSPECTS OF TRANSGENIC PLANTS, WHERE DO WE GO FROM HERE? A DIALOGUE BETWEEN BIOTECH INDUSTRY AND SCIENCE, 1999, : 199 - 203
  • [5] Nanoparticles in the environment: where do we come from, where do we go to?
    Mirco Bundschuh
    Juliane Filser
    Simon Lüderwald
    Moira S. McKee
    George Metreveli
    Gabriele E. Schaumann
    Ralf Schulz
    Stephan Wagner
    [J]. Environmental Sciences Europe, 2018, 30
  • [6] Elemental speciation: Where do we come from? where do we go?
    [J]. Adams, F.C. (freddy.adams@ua.ac.be), 1600, Royal Society of Chemistry (19):
  • [7] Nanoparticles in the environment: where do we come from, where do we go to?
    Bundschuh, Mirco
    Filser, Juliane
    Luderwald, Simon
    Mckee, Moira S.
    Metreveli, George
    Schaumann, Gabriele E.
    Schulz, Ralf
    Wagner, Stephan
    [J]. ENVIRONMENTAL SCIENCES EUROPE, 2018, 30
  • [8] Elemental speciation: where do we come from? where do we go?
    Adams, FC
    [J]. JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 2004, 19 (09) : 1090 - 1097
  • [9] Where do we stand on neuroprotection? Where do we go from here?
    Shoulson, I
    [J]. MOVEMENT DISORDERS, 1998, 13 : 46 - 48
  • [10] Tackling the problems of polypharmacy - Where do we stand and where should we go?
    Onder, G.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2015, 48 : 4 - 4